YBX1 and adenocarcinoma: High proportion of CDC25a expression in patients was increased following with the advance of pathological risk rating, but YBX1 expression (p= 0.156) had not displayed the association with pathological risk groups, suggesting that YBX1 expression maybe depend on the subtypes of adenocarcinoma or the number of high risk group was small (n=22).